Although the medical condition acromegaly may be fairly rare, for those who do live with the hormone disorder, it can cause a ...

Q1 2024 Earnings Call May 11, 2024 Crinetics Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds ...

Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal ...

H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on CRNX stock, giving a Buy rating today. Douglas Tsao has given his ...

Cory Jubinville, PhD, an analyst from LifeSci Capital, maintained the Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report).

Hello, and welcome to the OPKO Health first-quarter 2024 financial results conference call. [Operator instructions] Please ...

Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal Hyperplasia and ACTH-Dependent Cushing's Syndrome Will be Presented at ENDO June ...

Jeison Rodriguez Hernandez, a 28-year-old Venezuelan man with the world's largest feet, received custom-made shoes from a ...

May/1652024/pseb-class-11-biology-syllabus-2024-2025.jpg" width="1200" height="675" /> PSEB Class 11 Biology Syllabus: The ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified ...